Added to YB: 2024-09-25
Pitch date: 2024-09-25
AVG.L [bullish]
Avingtrans plc
+0%
current return
Author Info
No bio for this author
Company Info
Avingtrans plc, together with its subsidiaries, provides engineered components, systems, and services to the energy, medical, and infrastructure industries in the United Kingdom, rest of Europe, the United States of America, Africa, the Middle East, the Americas, the Carribean, China, and the Asia Pacific.
Market Cap
GBP 137.2M
Pitch Price
GBP 4.20
Price Target
5.25 (+25%)
Dividend
1.14%
Sector
Machinery
Category
growth
Avingtrans: Innovative Helium-Free MRI and 3D X-Ray Tech Drives Strong FY24 Growth
AVG.L: New helium-free MRI & 3D X-ray devices for community healthcare. FY24 sales +17.3% to £136.6m, EBITDA £14.0m. Medical div investing heavily (£3.7m rev, -£2.8m LBITDA). FDA approval mid-2025. £7bn market. Singer CM ups target to 525p, FY25 forecasts: £161m rev, £15m EBITDA, 14.3p EPS. Strong pipeline, 90% revenue cover.
Read full article (2 min)